Vice-Chair, Medicines for Europe, Biosimilar Medicines Group; Head of Clinical Development of Biologics, Gedeon Richter Plc.
Vice Chair, Department Clinical Pharmacology, Medical University of Vienna
Associate Professor, Section for Medical Statistics, Medical Unversity of Vienna
Statistician, Austrian Medicines and Medical Devices Agency; President, Viennese Section of IBS
Chief Scientific Officer, Accelsiors CRO Ltd.; President, Hungarian Society for Clinical Biostatistics
SPEAKERS, LECTURERS, SPECIAL GUESTS
The World’s prominent biosimilar development experts will return to Budapest in 2018 to the 3rd Annual Biosimilars Forum.
As in previous years, the programme of the event will be supported and complemented by international specialists from the biosimilars and nanosimilars area. The agenda and list of speakers of the forum will continue to expand until October with internationally renowned bio- and nanosimilar development experts from the fields of regulatory, academic and clinical research. Some specialists who accepted the invitation to participate at the 3rd Annual Biosimilars Forum :
President of Bawa Biotech LLC; Adjunct Professor at Rensselaer Polytechnic Institute, USA; Scientific Advisor at Teva Pharmaceutical Industries, Israel; Founding Director of American Society for Nanomedicine; USA
Marina A. DOBROVOLSKAIA
Senior Principal Scientist and Head of the Immunology Section at the Nanotechnology Characterization Laboratory, USA
Professor Emeritus from the University of Toronto, Canada; Former President of Canadian Society for Pharmaceutical Scientists, Canada
Hungarian member of EMA Committee for Human Medicinal Products (CHMP), and EMA Paediatric Committee (PDCO); Unit Head at National Institute of Pharmacy and Nutrition, Hungary
Ludwig A. HOTHORN
Professor of Biostatistics at Leibniz Universität Hannover, Faculty of Natural Sciences, Hannover, Germany
Professor of Statistics, Medical and Pharmaceutical Statistics Research Unit, Department of Mathematics and Statistics, Lancaster University, UK
European Regulatory Expert; Unit Head, Austrian Medicines and Medical Devices Agency, Austria
Deputy Director Research Design and Conduct Service and Research Fellow, Cardiff University, UK
Professor of Targeted Nanomedicine at the University of Utrecht; Professor of Targeted Therapeutics at the MIRA Institute of the University of Twente; The Netherlands
Director of the Nanomedicine Research and Education Center of Semmelweis Medical University, Budapest, Hungary
Head of Biostatistics and Data Management,
Director Biostatistics for Biostatistics Biosimilars, Analytics group,
Early Stage Researcher; Biostatistician, Novartis Pharma AG, Switzerland
Tickets are available now with flexible terms. Please send us your registration as soon as possible because places are limited in number! WBS and ISCB members can attend the 2nd day symposium for free.
Join us for discovery, networking and meet leading biosimilar development experts at our Forum!
SOME SPEAKERS FROM OUR PREVIOUS FORUMS
Professor, Department of Biostatistics and Bioinformatics, Duke University School of Medicine, USA
Professor Emeritus of Pharmacology and Biostatistics, University of Toronto, Canada
Vice Chair, Department Clinical Pharmacology, Medical University of Vienna, Austria
Unit Head, Austrian Medicines and Medical Devices Agency, Austria
Owner at BEBAC – Consultancy Services for Bioequivalence and Bioavailability Studies, Austria
Director of the Nanomedicine Research and Education Center, Semmelweis Medical University, Budapest, Hungary